GSK And Pfizer Assemble Consumer Healthcare Leadership Team As JV Closes
Under Brian McNamara’s leadership, GSK Consumer Healthcare has begun to assemble a management team that combines talent from both GSK and Pfizer.
You may also be interested in...
UK TV commercial for GSK's Nexium Control acid reflux treatment investigated by Advertising Standards Authority after complaint alleged promotion was irresponsible and potentially harmful. ASA found no wrongdoing by GSK and judged firm didn't breach UK Code of Broadcast Advertising.
Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.
GSK will demerge its Consumer Healthcare business in mid-2022 and list the new company on the London Stock Exchange. The move will “create new world leader in consumer healthcare,” according to GSK, with annual sales in excess of £10bn.